NeXtGen Biologics Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
NeXtGen Biologics General Information
Description
Developer of extracellular matrix biomaterial products designed to harness axolotl-derived extracellular matrix components for tissue regeneration. The company offers a collagen wound matrix sourced from the axolotl's extracellular matrix to better manage complex conditions seen in general surgery, trauma, cardiovascular diseases, neurosurgery, orthopedics, and ophthalmology, enabling clinicians treating partial- and full-thickness wounds to support healing and improve the wound environment.
Contact Information
Website
www.nextgenbiologics.comCorporate Office
- 13200 Tech City Cir
- Suite 100
- Alachua, FL 32615
- United States
Corporate Office
- 13200 Tech City Cir
- Suite 100
- Alachua, FL 32615
- United States
NeXtGen Biologics Timeline
NeXtGen Biologics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Secondary Transaction - Private | 01-Feb-2026 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 22-Sep-2025 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 01-Oct-2023 | Completed | Generating Revenue | |||
| 6. Equity Crowdfunding | 01-Mar-2023 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 14-Aug-2020 | Completed | Generating Revenue | |||
| 4. Debt - PPP | 07-Apr-2020 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 06-Apr-2017 | Completed | Startup | |||
| 2. Seed Round | 03-Nov-2016 | $1.5M | $4.08M | Completed | Startup | |
| 1. Seed Round | 30-Nov-2015 | $2.58M | $2.58M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
NeXtGen Biologics Patents
NeXtGen Biologics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2943209-A1 | Decellularized biomaterial form non-mammalian tissue | Active | 09-Jan-2013 | ||
| EP-2943209-A4 | Decellularized biomaterial form non-mammalian tissue | Active | 09-Jan-2013 | ||
| EP-2943209-B1 | Decellularized biomaterial form non-mammalian tissue | Active | 09-Jan-2013 | ||
| EP-2943209-B8 | Decellularized biomaterial form non-mammalian tissue | Active | 09-Jan-2013 | ||
| CA-2897662-A1 | Decellularized biomaterial from non-mammalian tissue | Active | 09-Jan-2013 | A61L27/3687 |
NeXtGen Biologics Signals
NeXtGen Biologics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Varia Ventures | Venture Capital | Minority |
NeXtGen Biologics FAQs
-
When was NeXtGen Biologics founded?
NeXtGen Biologics was founded in 2014.
-
Where is NeXtGen Biologics headquartered?
NeXtGen Biologics is headquartered in Alachua, FL.
-
What is the size of NeXtGen Biologics?
NeXtGen Biologics has 7 total employees.
-
What industry is NeXtGen Biologics in?
NeXtGen Biologics’s primary industry is Other Devices and Supplies.
-
Is NeXtGen Biologics a private or public company?
NeXtGen Biologics is a Private company.
-
What is NeXtGen Biologics’s current revenue?
The current revenue for NeXtGen Biologics is .
-
How much funding has NeXtGen Biologics raised over time?
NeXtGen Biologics has raised $6.7M.
-
Who are NeXtGen Biologics’s investors?
Varia Ventures has invested in NeXtGen Biologics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process